Mythic Therapeutics

Drug Discovery · Waltham, MA · Founded 2017 · Out of Business

Developer of a biotechnology product platform designed to deliver chemotherapy directly to tumors through antibody-drug conjugates. Mythic Therapeutics is based in Waltham, MA and was founded in 2017. Its last known valuation is $293 million (Dec 2021). It has raised $156 million across 4 recorded rounds; the latest was a $29.9 million early-stage round in Dec 2024.

Last price · $/share
—
Implied valuation
$293.0M
Total raised
$156.5M
Last round
Early Stage VC
Dec 2024
What is Mythic Therapeutics worth?
$293.0Mlast known valuation

Mythic Therapeutics last raised $29.9M in its Early Stage VC (Dec 2024).

Free account
More of Mythic Therapeutics with a free account
  • ·The complete investor list: 17 names
  • ·Watch Mythic Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mythic Therapeutics funding history

4 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$29.9M▮
Dec 2021Early Stage VC (Series B)$103.0M▮
Jul 2020Early Stage VC$18.8M▮
Jun 2018Seed Round$4.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Mythic Therapeutics valuation

Mythic Therapeutics's last known valuation is $293 million, from Dec 2021. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Mythic Therapeutics raised?

Mythic Therapeutics has raised $156 million across 4 recorded rounds since 2018. The largest was a $4.7 million seed round in Jun 2018; the most recent was a $29.9 million early-stage round in Dec 2024.

Mythic Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Dec 2024 ($29.9 million sold to 30 investors).

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: City Therapeutics ($285 million), Convergent Therapeutics ($280 million) and Ensoma ($280 million).

How Mythic Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Mythic Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Mythic Therapeutics

What is Mythic Therapeutics worth?
Mythic Therapeutics's last known valuation is $293.0M.
How much has Mythic Therapeutics raised?
Mythic Therapeutics has raised $156.5M in total funding across 4 recorded rounds.
When did Mythic Therapeutics last raise?
Mythic Therapeutics last raised in Dec 2024 (Early Stage VC), raising $29.9M.